Home > Publications database > Wet Chemical Etching of Si, Si1-xGex, and Ge in HF:H2O2:CH3COOH > print |
001 | 9643 | ||
005 | 20180208195229.0 | ||
024 | 7 | _ | |2 DOI |a 10.1149/1.3382944 |
024 | 7 | _ | |2 WOS |a WOS:000277260200080 |
024 | 7 | _ | |2 ISSN |a 0013-4651 |
024 | 7 | _ | |2 ISSN |a 0096-4743 |
024 | 7 | _ | |2 ISSN |a 0096-4786 |
024 | 7 | _ | |2 ISSN |a 1945-7111 |
037 | _ | _ | |a PreJuSER-9643 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 540 |
084 | _ | _ | |2 WoS |a Electrochemistry |
084 | _ | _ | |2 WoS |a Materials Science, Coatings & Films |
100 | 1 | _ | |0 P:(DE-Juel1)125595 |a Holländer, B. |b 0 |u FZJ |
245 | _ | _ | |a Wet Chemical Etching of Si, Si1-xGex, and Ge in HF:H2O2:CH3COOH |
260 | _ | _ | |a Pennington, NJ |b Electrochemical Society |c 2010 |
300 | _ | _ | |a H643 - H646 |
336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a article |2 DRIVER |
440 | _ | 0 | |0 3889 |a Journal of the Electrochemical Society |v 157 |x 0013-4651 |y 6 |
500 | _ | _ | |a This work was supported by the European Commission, Information Society Technology (IST), within the framework of PULLNANO, contract no. IST-026828. |
520 | _ | _ | |a This open-label extension evaluated the long-term efficacy and tolerability of rufinamide in patients with Lennox-Gastaut syndrome (LGS) who had previously completed a 12-week double-blind study.In total, 124 patients (aged 4-37 years), receiving 1-3 concomitant antiepileptic drugs, were treated with rufinamide approximately 25-60 mg/kg/day. Efficacy was assessed by seizure frequency; tolerability by adverse events (AEs) and laboratory tests.Overall, patients were treated with rufinamide for a median (range) of 432 (10-1149) days. Reductions in seizure frequency were observed throughout the study; during the last 12 months of treatment, 41.0% and 47.9% of patients had > or = 50% reduction in total and tonic-atonic seizure frequency, respectively. The most common AEs were vomiting (30.6%) and pyrexia (25.8%).In this open-label extension, rufinamide appeared to be an effective long-term adjunctive therapy for the treatment of LGS-associated seizures in children and young adults. |
536 | _ | _ | |0 G:(DE-Juel1)FUEK412 |2 G:(DE-HGF) |a Grundlagen für zukünftige Informationstechnologien |c P42 |x 0 |
588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
650 | _ | 7 | |2 WoSType |a J |
700 | 1 | _ | |0 P:(DE-Juel1)125569 |a Buca, D. |b 1 |u FZJ |
700 | 1 | _ | |0 P:(DE-Juel1)VDB4959 |a Mantl, S. |b 2 |u FZJ |
700 | 1 | _ | |0 P:(DE-HGF)0 |a Hartmann, J.M. |b 3 |
773 | _ | _ | |0 PERI:(DE-600)2002179-3 |a 10.1149/1.3382944 |g Vol. 157, p. H643 - H646 |p H643 - H646 |q 157 |v 157 |x 0013-4651 |y 2010 |
856 | 7 | _ | |u http://dx.doi.org/10.1149/1.3382944 |
909 | C | O | |o oai:juser.fz-juelich.de:9643 |p VDB |
913 | 1 | _ | |0 G:(DE-Juel1)FUEK412 |a DE-HGF |b Schlüsseltechnologien |k P42 |l Grundlagen für zukünftige Informationstechnologien (FIT) |v Grundlagen für zukünftige Informationstechnologien |x 0 |
914 | 1 | _ | |y 2010 |
915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
920 | 1 | _ | |d 31.12.2010 |g IBN |k IBN-1 |l Halbleiter-Nanoelektronik |0 I:(DE-Juel1)VDB799 |x 0 |
920 | 1 | _ | |0 I:(DE-82)080009_20140620 |k JARA-FIT |l Jülich-Aachen Research Alliance - Fundamentals of Future Information Technology |g JARA |x 1 |
970 | _ | _ | |a VDB:(DE-Juel1)119578 |
980 | _ | _ | |a VDB |
980 | _ | _ | |a ConvertedRecord |
980 | _ | _ | |a journal |
980 | _ | _ | |a I:(DE-Juel1)PGI-9-20110106 |
980 | _ | _ | |a I:(DE-82)080009_20140620 |
980 | _ | _ | |a UNRESTRICTED |
981 | _ | _ | |a I:(DE-Juel1)PGI-9-20110106 |
981 | _ | _ | |a I:(DE-Juel1)VDB881 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|